Previous 10 | Next 10 |
Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded today at $86.44, eclipsing its 52-week high. Approximately 12.2 million shares have changed hands today, as compared to an average 30-day volume of 187,000 shares. ANI Pharmaceuticals Inc. (NASDAQ:ANIP) is currently priced 2.0% abov...
Shares of ANI Pharmaceuticals Inc. (NASDAQ:ANIP) traded at a new 52-week high today of $86.44. This new high was reached on above average trading volume as 12.2 million shares traded hands, while the average 30-day volume is approximately 188,000 shares. Based on a current price of $28.9...
“Meme stocks” GameStop and AMC Entertainment saw their stocks surge last week. GameStop registered a gain of over 67% for the week. Billionaire founder of online pet retailer Chewy, Ryan Cohen, Alain Attal, a Chewy executive, and Lawrence Cheng, a Managing Partner of...
-- Dr. Tannenbaum’s successful track record in driving commercial excellence to contribute as Company executes Purified Cortrophin Gel TM launch -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced the addition of Renee P. Tannenbaum, P...
Lower oil prices and hope of a negotiated end to the conflict in Ukraine contributed to a stock rebound on Tuesday. The Nasdaq led the advance, climbing by about 2.9%, while the S&P 500 posted a gain of 2.1%. Airline stocks had a particularly strong day, bolstered by the drop in crude and...
ANI Pharmaceuticals, Inc. (ANIP) Q4 2021 Earnings Conference Call March 15, 2022, 08:30 ET Company Participants Judy DiClemente - IR Nikhil Lalwani - President, CEO & Director Stephen Carey - SVP, Finance & CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. ...
Gainers: Incannex Healthcare Limited (NASDAQ:IXHL) +176%. Revelation Biosciences (NASDAQ:REVB) +34%. Kaival Brands Innovations (NASDAQ:KAVL) +29%. Rapid Micro Biosystems (NASDAQ:RPID) +25%. Summer Infant (NASDAQ:SUMR) +22%. Kingsoft Cloud (NASDAQ:KC) +21%. RLX Technology (NYSE:RLX) +20%. Sone...
The shares of ANI Pharmaceuticals (ANIP -24.3%) have approached the lowest level since August after the maker of branded and generic medicines posted a lower than expected guidance for 2022. Net revenue for the quarter rose ~6% YoY to $60.9M as revenue from generic pharmaceuticals jumped...
Gainers: Incannex Healthcare IXHL +209%. Revelation Biosciences (NASDAQ:REVB) +25%. Co-Diagnostics CODX +14%. GreenLight Biosciences (NASDAQ:GRNA) +14%. Clearside Biomedical (NASDAQ:CLSD) +12%. Losers: Better Therapeutics BTTX -33%. ANI Pharmaceuticals ...
ANI Pharmaceuticals press release (NASDAQ:ANIP): Q4 GAAP EPS of $0.54 beats by $0.68. Revenue of $60.9M (+6.3% Y/Y) beats by $4.6M. Cash and cash equivalents were $100.3 million, net accounts receivable was $128.5 million, and face value of debt was $300.0 million as of December 31, 2021. Gui...
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Po...
2024-07-09 17:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP....